Navigation Links
Marijuana Use Can Up Psychosis Risk
Date:2/27/2010

Study found the longer teens smoked, the more their mental health suffered

SATURDAY, Feb. 27 (HealthDay News) -- Long-term use of marijuana can lead to increased risk of developing hallucinations, delusions and psychosis, a new study shows.

Australian researchers asked nearly 3,100 young adults averaging about 20 years of age about marijuana use. They found that almost 18 percent reported using the drug for three or fewer years, about 16 percent for four to five years, and just over 14 percent for six or more years.

Among the participants, 65 had been diagnosed with a "non-affective psychosis" such as schizophrenia, and 233 had at least one positive item for hallucination on a diagnostic interview conducted for the study.

The researchers found there was an association between length of marijuana use and mental health.

"Compared with those who had never used cannabis, young adults who had six or more years since first use of cannabis [i.e., who commenced use when around 15 years or younger] were twice as likely to develop a non-affective psychosis and were four times as likely to have high scores on the Peters et al Delusions Inventory [a measure of delusion]," wrote Dr. John McGrath, of the Queensland Centre for Mental Health Research, Park Centre for Mental Health in Wacol, and colleagues. "There was a 'dose-response' relationship between the variables of interest: the longer the duration since the first cannabis use, the higher the risk of psychosis-related outcomes."

The study appears online March 1 and in the May print issue of the Archives of General Psychiatry.

But the association between psychosis and marijuana use is not simple, the researchers noted. They found that people who'd experienced hallucinations earlier in life were also more likely to have used marijuana longer and to use it more frequently.

"This demonstrates the complexity of the relationship: those individuals who were vulnerable to psychosis [i.e., those who had isolated psychotic symptoms] were more likely to commence cannabis use, which could then subsequently contribute to an increased risk of conversion to a non-affective psychotic disorder," wrote the study authors.

Further research is needed to learn more about the mechanisms underlying the association between psychosis and marijuana use, they concluded.

More information

The U.S. National Institute on Drug Abuse has more about marijuana.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, March 1, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
2. International Merchant Advisors Inc. to Open New Wellness Centers With Medical Marijuana Treatment Facilities
3. UC studies show marijuana has therapeutic value, reports to legislature
4. Marijuana ineffective as an Alzheimers treatment: UBC-Vancouver Coastal Health research
5. 215 Agenda Medical Marijuana Collective Located in Lake Forest, CA, has Donated $1,500 to Friends of the El Toro Library
6. Medical Marijuana Super Store Opens in East Oakland
7. Marijuana Compounds Could Beat Back Brain Cancer
8. Marijuana Munchies May Be Rooted in Biology
9. Teen Marijuana Use Might Have Lasting Effects on Mood, Anxiety
10. Pot and pop: New research finds stronger link between music and marijuana use among teens
11. Marijuana, Alcohol Addiction May Share Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... IT operations analytics and application performance monitoring (APM) solutions, has expanded its ... services providers. , According to Peter Ohrenberger, sales director at Nastel, “We’ve ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... platform, in which their iMedSecure™ comes included with each system installation. RMT’s ... images to remote participants for real-time collaboration and immediate decision-making requirements. While ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar ... non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it has ... to complete regulatory submissions and fund final engineering and initial production of the ...
(Date:7/20/2017)... , ... July 20, 2017 , ... The Dermatology Clinic ... Dr. Dunbar received his BS in Biology from LSU, graduating summa cum laude. He ... Class President. After his residency in St. Louis, Dr. Dunbar moved to New York ...
(Date:7/20/2017)... CA (PRWEB) , ... July 20, 2017 , ... ... A Guide to the Business Architecture Body of Knowledge (BIZBOK® Guide )v 6.0 ... members who contributed to this effort through Guild collaborative teams. , Non-members may ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... -- Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials proves ... to progress molecular radiotherapy imaging. In molecular radiotherapy ... accurately quantify the radiation absorbed by those patients undergoing treatment. ... this radiotherapy treatment has been available — that is, until ... ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
(Date:6/30/2017)... June 30, 2017  AVACEN Medical (AVACEN) announced the publication of ... describes the use of its AVACEN Treatment Method to ... fibromyalgia. ... AVACEN Medical ... chronic widespread pain. It affects approximately 200 to 400 million people worldwide ...
Breaking Medicine Technology: